A Phase 2 Randomised Controlled Trial of Sodium Selenate as a Disease Modifying Treatment for Chronic Drug-resistant Temporal Lobe Epilepsy - The SeLECT Study
收藏Research Data Australia2024-08-03 收录
下载链接：
https://researchdata.edu.au/a-phase-2-select-study/2760891
下载链接
链接失效反馈官方服务：
资源简介：
Sodium selenate, 15mg three times a day, 26 weeks, oral tablet. Participants will be required to return unused tablets to site each visit to monitor compliance with dosing regimen.
提供机构：
Monash University
